Vestiage, Inc.

VEST

US92548W1053

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 20:58:19 29/04/2024 BST			5-day change	1st Jan Change
0.021 ^USD	-.--%		-.--%	+4.48%

04-16	Vestiage, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vestiage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Vestiage, Inc. announced that it has received funding

October 01, 2013

Vestiage, Inc. (OTCPK:VEST) announced a private placement of convertible debt and restricted common shares on October 2, 2013. The transaction included participation from notable wealthy Boston and East Coast-based families. The company completed the transaction without the use of a broker.

On October 2, 2013, Vestiage, Inc. closed the transaction.

Latest news about Vestiage, Inc.

Vestiage, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Vestiage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-21	CI
Vestiage, Inc. Announces CEO Changes	29/08/23	CI
Vestiage, Inc. Appoints Raymond Fu as its CFO	29/08/23	CI
Vestiage, Inc. Announces Executive Changes	29/08/23	CI
Vestiage, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
Vestiage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Vestiage, Inc. Provides Earnings Guidance for the Fourth Quarter of 2014	01/02/15	CI
Vestiage, Inc. cancelled the transaction announced on December 20, 2013.	20/12/14	CI
Vestiage, Inc. Announces the Availability of Regimen Products in Vitamin Shoppe Retail Stores	09/09/14	CI
Vestiage Announces Executive Appointments	04/09/14	CI
Vestiage, Inc. Receives Purchase Order from The Vitamin Shoppe	26/08/14	CI
Vestiage, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014	14/08/14	CI
Empowered Products, Inc. and Vestiage, Inc. Enter Joint Marketing Agreement	08/07/14	CI
Vestiage, Inc. announced that it has received funding from Media Funding Group.	25/06/14	CI
Vestiage Inc. Appoints Laura Stall to National VP of Sales	19/06/14	CI
Vestiage, Inc. announced that it has received funding from Media Funding Group.	08/05/14	CI
Vestiage, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014	06/05/14	CI
Vestiage, Inc. Reveals Two New Products	02/04/14	CI
Vestiage, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2013	11/03/14	CI
Vestiage, Inc. Names Laura Stall as Vice President, Nutraceuticals Sales, Western Region	10/02/14	CI
Vestiage's RegiMEN(TM) Brand to Be Distributed by Europa Sports Products	30/01/14	CI
Vestiage Adds to Advisory Committee in Fourth Quarter	30/12/13	CI
Vestiage, Inc. announced that it expects to receive $4.38 million in funding.	20/12/13	CI
Vestiage, Inc. announced that it has received funding	01/10/13	CI

Chart Vestiage, Inc.

Duration

Period

More charts

Company Profile

Vestiage, Inc. is a developmental stage company. The Company is in the fitness event planning industry. The Company specialize in the planning of events and competitions for fitness gyms within the functional fitness space. It sponsors competitions within local communities and organize events, such as parties and educational seminars. Its services include competition planning, vendor organization, food services, securing competition equipment and volunteers to work the event. It also plans parties for local gyms such for holiday and new member celebrations. The Companyâs subsidiary is Fun Fitness Corporation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VESTIAGE, INC.	+4.48%	1.22M
ELI LILLY AND COMPANY	+38.69%	723B
NOVO NORDISK A/S	+34.28%	595B
JOHNSON & JOHNSON	-4.49%	369B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.31%	208B
ROCHE HOLDING AG	-5.07%	205B
PFIZER, INC.	-0.35%	168B